Cited by 209Parkinson's Disease Mechanisms and TreatmentsNeural and Behavioral Psychology StudiesNeurotransmitter Receptor Influence on Behavior

Dopamine agonists and risk: impulse control disorders in Parkinson's; disease

Open access
Voon, Valerie, Gao, Jennifer, Brezing, Christina, Symmonds, Mkael, Ekanayake, Vindhya, Fernandez, Hubert, Dolan, Raymond J., Hallett, Mark·2011·Brain

Abstract

Impulse control disorders are common in Parkinson's disease, occurring in 13.6% of patients. Using a pharmacological manipulation and a novel risk taking task while performing functional magnetic resonance imaging, we investigated the relationship between dopamine agonists and risk taking in patients with Parkinson's disease with and without impulse control disorders. During functional magnetic resonance imaging, subjects chose between two choices of equal expected value: a 'Sure' choice and a 'Gamble' choice of moderate risk. To commence each trial, in the 'Gain' condition, individuals started at $0 and in the 'Loss' condition individuals started at -$50 below the 'Sure' amount. The difference between the maximum and minimum outcomes from each gamble (i.e. range) was used as an index of risk ('Gamble Risk'). Sixteen healthy volunteers were behaviourally tested. Fourteen impulse control disorder (problem gambling or compulsive shopping) and 14 matched Parkinson's disease controls were tested ON and OFF dopamine agonists. Patients with impulse control disorder made more risky choices in the 'Gain' relative to the 'Loss' condition along with decreased orbitofrontal cortex and anterior cingulate activity, with the opposite observed in Parkinson's disease controls. In patients with impulse control disorder, dopamine agonists were associated with enhanced sensitivity to risk along with decreased ventral striatal activity again with the opposite in Parkinson's disease controls. Patients with impulse control disorder appear to have a bias towards risky choices independent of the effect of loss aversion. Dopamine agonists enhance sensitivity to risk in patients with impulse control disorder possibly by impairing risk evaluation in the striatum. Our results provide a potential explanation of why dopamine agonists may lead to an unconscious bias towards risk in susceptible individuals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awr080

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Administering specific dopamine agonists can activate previously non-existent behaviors such as compulsive gambling, compulsive eating, hypersexuality, and compulsive shopping.

    “Thus, administering specific dopamine agonists can activate previously non-existent behaviors, such as compulsive gambling, compulsive eating, hypersexuality, and compulsive shopping (18–21).”

    From Cell-phone addiction: a review (2016) · cites this paper as [20]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Markowitz H. Portfolio selection. J Finance 1952; 7: 77-91.

Cited by

Sorted by citations

Authors
Voon, V., Gao, J., Brezing, C., Symmonds, M., Ekanayake, V., Fernandez, H., Dolan, R. J., & Hallett, M.
Affiliations
  • National Institutes of Health (US)
  • Wellcome Centre for Human Neuroimaging (GB)
  • University of Florida (US)
Venue
Brain
Published
2011-05
Volume
134
Issue
5
Pages
1438-1446
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W1999635028
Cited by
209
References
28
Citations by year
2026: 3 · 2025: 7 · 2024: 5 · 2023: 5 · 2022: 10 · 2021: 16 · 2020: 17 · 2019: 17 · 2018: 15 · 2017: 14 · 2016: 20 · 2015: 16 · 2014: 16 · 2013: 27 · 2012: 16
FWCI
12.98
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Max Planck Digital Library (submittedVersion, other-oa)
  • MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
Funders
National Institutes of Health
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
dopamine agonists, impulse control disorders, Parkinson's disease, risk-taking, risk sensitivity, orbitofrontal cortex, anterior cingulate cortex, ventral striatum, loss aversion, problem gambling, compulsive buying, pharmacological manipulation
MeSH terms
Adult, Aged, Analysis of Variance, Brain Mapping, Female, Humans, Image Processing, Computer-Assisted, Disruptive, Impulse Control, and Conduct Disorders, Magnetic Resonance Imaging, Male, Middle Aged, Oxygen, Parkinson Disease, Risk Factors, Risk-Taking, Dopamine Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review